Elena Alifanova

Elena Alifanova has been a Research Scientist at Tioga Research since its founding in 2011 and has over ten years of experience in biochemical laboratory studies and formulation development. During her tenure at Tioga Research, Elena has designed, managed, and performed Standard Operation Procedures (“SOP”s) for a variety of advanced formulation development, stability and solubility studies for topical and transdermal drug delivery using Tioga Research HTE platforms, Franz diffusion cells, flow-through permeation cells, radiolabeling, and robotic metrology for identifying high-performing formulations.

Prior to launch of Tioga Research, Elena spent over five years as a Research Technologist at Nuvo Research U.S. where she was responsible for high throughput formulation screening campaigns, permeation measurements and ELISA assays; she also developed SOPs and qualification reports, and contributed to the development of several formulation innovations, such as PENNSAID 2% for treatment of osteoarthritis of the knee. Prior to joining Nuvo Research, Elena held positions as a Research and Laboratory Associate at research institutions in Russia where she conducted experimental studies of blood samples using erythrocytapheresis. Elena holds an M.S. in Biochemistry from Nizhny Novgorod State University, Russia.